Cargando…

Wild-type GBA1 increases the α-synuclein tetramer–monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice

Loss-of-function mutations in acid beta-glucosidase 1 (GBA1) are among the strongest genetic risk factors for Lewy body disorders such as Parkinson’s disease (PD) and Lewy body dementia (DLB). Altered lipid metabolism in PD patient–derived neurons, carrying either GBA1 or PD αS mutations, can shift...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glajch, Kelly E., Moors, Tim E., Chen, Yi, Bechade, Pascal A., Nam, Alice Y., Rajsombath, Molly M., McCaffery, Thomas D., Dettmer, Ulf, Weihofen, Andreas, Hirst, Warren D., Selkoe, Dennis J., Nuber, Silke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2021
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346893/ https://www.ncbi.nlm.nih.gov/pubmed/34326260 http://dx.doi.org/10.1073/pnas.2103425118

Ejemplares similares

Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
por: Dettmer, Ulf, et al.
Publicado: (2015)

A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein Mice
por: Nuber, Silke, et al.
Publicado: (2020)

Corrigendum: Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
por: Dettmer, Ulf, et al.
Publicado: (2015)

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
por: Bartels, Tim, et al.
Publicado: (2011)

A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
por: Nuber, Silke, et al.
Publicado: (2022)

Correction to: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
por: Nuber, Silke, et al.
Publicado: (2022)

Perturbation of the Monomer–Monomer Interfaces of the Benzoylformate Decarboxylase Tetramer
por: Andrews, Forest H., et al.
Publicado: (2014)

A New Method for Quantitative Immunoblotting of Endogenous α-Synuclein
por: Newman, Andrew J., et al.
Publicado: (2013)

Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase
por: Imberdis, Thibaut, et al.
Publicado: (2019)

Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation
por: Galvagnion, Céline, et al.
Publicado: (2022)

Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity
por: Ramalingam, Nagendran, et al.
Publicado: (2023)

Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution
por: Li, Xi, et al.
Publicado: (2019)

Saturation mutagenesis of α-synuclein reveals monomer fold that modulates aggregation
por: Chlebowicz, Julita, et al.
Publicado: (2023)

Purification of α-Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity
por: Luth, Eric S., et al.
Publicado: (2014)

The Parkinson’s disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium release
por: Apicco, Daniel J., et al.
Publicado: (2021)

Enriched environment enhances β‐adrenergic signaling to prevent microglia inflammation by amyloid‐β
por: Xu, Huixin, et al.
Publicado: (2018)

Cyclized NDGA modifies dynamic α-synuclein monomers preventing aggregation and toxicity
por: Daniels, Malcolm J., et al.
Publicado: (2019)

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
por: Yun, Seung Pil, et al.
Publicado: (2018)

The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines
por: Smith, Laura J, et al.
Publicado: (2022)

Muscle myosins form folded monomers, dimers, and tetramers during filament polymerization in vitro
por: Liu, Xiong, et al.
Publicado: (2020)

Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s disease
por: Fonseca-Ornelas, Luis, et al.
Publicado: (2021)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
por: Brockmann, Kathrin
Publicado: (2020)

The Subcellular Localization of an Aquaporin-2 Tetramer Depends on the Stoichiometry of Phosphorylated and Nonphosphorylated Monomers
por: Kamsteeg, E.J., et al.
Publicado: (2000)

Role of Monomer/Tetramer Equilibrium of Rod Visual Arrestin in the Interaction with Phosphorylated Rhodopsin
por: Imamoto, Yasushi, et al.
Publicado: (2023)

The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models
por: Polinski, Nicole K., et al.
Publicado: (2022)

Soluble Aβ Oligomers Impair Dipolar Heterodendritic Plasticity by Activation of mGluR in the Hippocampal CA1 Region
por: Zhao, Jianhua, et al.
Publicado: (2018)

Pathway and Mechanism of pH Dependent Human Hemoglobin Tetramer-Dimer-Monomer Dissociations
por: Huang, Yao-Xiong, et al.
Publicado: (2013)

Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
por: Behl, Tapan, et al.
Publicado: (2021)

Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity
por: Kim, Tae-Eun, et al.
Publicado: (2021)

α-Synuclein serine129 phosphorylation – the physiology of pathology
por: Ramalingam, Nagendran, et al.
Publicado: (2023)

The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
por: García‐Sanz, Patricia, et al.
Publicado: (2020)

pH-Dependent Conformational Changes of KcsA Tetramer and Monomer Probed by Raman Spectroscopy
por: Kniggendorf, Ann-Kathrin, et al.
Publicado: (2019)

Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
por: Fonseca-Ornelas, Luis, et al.
Publicado: (2022)

Parkinson’s disease: proteinopathy or lipidopathy?
por: Fanning, Saranna, et al.
Publicado: (2020)

Rationally Designed Variants of α-Synuclein Illuminate Its in vivo Structural Properties in Health and Disease
por: Dettmer, Ulf
Publicado: (2018)

A β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons
por: Szegő, Éva M., et al.
Publicado: (2021)

Impact of Gba2 on neuronopathic Gaucher’s disease and α-synuclein accumulation in medaka (Oryzias latipes)
por: Nakanishi, Etsuro, et al.
Publicado: (2021)

Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons
por: Ramalingam, Nagendran, et al.
Publicado: (2021)

rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration
por: Oliveras-Salvá, Marusela, et al.
Publicado: (2013)

Structural insights into α-synuclein monomer–fibril interactions
por: Kumari, Pratibha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0jotbq2ccugc7df9o2stsl1699